https://doi.org/10.3390/ijms23020786
Y
Youssef Bouferraa
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
1.6K
Citations
12
h-index
13
i10-index
Youssef Bouferraa is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Colorectal Cancer Surgical Treatments & Colorectal and Anal Carcinomas & Cancer Immunotherapy and Biomarkers. The author has an h-index of 12, co-authored 26 publications.
ORCID: 0000-0003-1704-3712Papers by this author
worksMetabolic Syndrome: Updates on Pathophysiology and Management in 2021
2022 · International Journal of Molecular Sciences · 1,306 citations
Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota
2023 · International Journal of Molecular Sciences · 14 citations
https://doi.org/10.3390/ijms24119702
A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO)
2022 · BMC Cancer · 8 citations
https://doi.org/10.1186/s12885-022-10373-1
Complete Radiological Response of Recurrent Metastatic Adrenocortical Carcinoma to Pembrolizumab and Mitotane
2021 · Clinical Medicine Insights Oncology · 4 citations
https://doi.org/10.1177/11795549211007682
Total neoadjuvant therapy in early-onset versus average-onset locally advanced rectal cancer: patient characteristics and tolerance of therapy
2025 · ESMO Gastrointestinal Oncology · 0 citations
https://doi.org/10.1016/j.esmogo.2025.100170
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat